BDBM100864 US8507533, 193

SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(Nc1cnc(nc1)-n1cnc(c1)C(F)(F)F)C1CCCC1

InChI Key InChIKey=KUIQXXFGGIPRIS-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 100864   

TargetPro-glucagon(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM100864(US8507533, 193)
Affinity DataKi:  44.7nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent